BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9753710)

  • 21. Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Colantuoni V; Riccardi G
    Int J Obes Relat Metab Disord; 2000 Sep; 24(9):1195-9. PubMed ID: 11033990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Renn W; Häring HU
    Diabetologia; 1999 Jun; 42(6):758-62. PubMed ID: 10382597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genetic mutation in PPAR gamma is associated with enhanced fat cell differentiation: implications for human obesity.
    Freake HC
    Nutr Rev; 1999 May; 57(5 Pt 1):154-6. PubMed ID: 10391018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A mutation detection in a transcription factor for adipocyte development in children with severe obesity.].
    Agústsson TT; Hákonarson H; Olafsson I; Hjaltadóttir G; Thornórsson AV
    Laeknabladid; 2001 Feb; 87(2):119-24. PubMed ID: 16940676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WNT10B mutations in human obesity.
    Christodoulides C; Scarda A; Granzotto M; Milan G; Dalla Nora E; Keogh J; De Pergola G; Stirling H; Pannacciulli N; Sethi JK; Federspil G; Vidal-Puig A; Farooqi IS; O'Rahilly S; Vettor R
    Diabetologia; 2006 Apr; 49(4):678-84. PubMed ID: 16477437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inconsistent effects of the proline12 --> alanine variant of the peroxisome proliferator-activated receptor-gamma2 gene on body mass index in children and adolescent girls.
    Witchel SF; White C; Siegel ME; Aston CE
    Fertil Steril; 2001 Oct; 76(4):741-7. PubMed ID: 11591408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
    Shuldiner AR; Nguyen W; Kao WH; Beamer BA; Andersen RE; Pratley R; Brancati FL
    Diabetes Care; 2000 Jan; 23(1):126-7. PubMed ID: 10857984
    [No Abstract]   [Full Text] [Related]  

  • 28. Unraveling obesity.
    Hom X; Kleinman R
    J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):121-2. PubMed ID: 9932837
    [No Abstract]   [Full Text] [Related]  

  • 29. The adipocyte: storage depot or node on the energy information superhighway?
    Flier JS
    Cell; 1995 Jan; 80(1):15-8. PubMed ID: 7813011
    [No Abstract]   [Full Text] [Related]  

  • 30. Adipose tissue growth and differentiation: view from the chair.
    Lau DC
    Int J Obes Relat Metab Disord; 2000 Nov; 24 Suppl 4():S20-2. PubMed ID: 11126234
    [No Abstract]   [Full Text] [Related]  

  • 31. Pluripotent PPARgamma polymorphisms.
    Berg JP
    Eur J Endocrinol; 1999 Apr; 140(4):293-5. PubMed ID: 10097247
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetics of obesity: more complicated than initially thought.
    Shuldiner AR; Munir KM
    Lipids; 2003 Feb; 38(2):97-101. PubMed ID: 12733739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preface.
    Forrest D; Tsai S
    Curr Top Dev Biol; 2017; 125():xv-xvi. PubMed ID: 28527582
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulations of Adipocyte Phenotype and Obesity by IRX3. Positive or Negative?
    Inagaki T
    EBioMedicine; 2017 Oct; 24():7-8. PubMed ID: 28967609
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.
    Beamer BA; Yen CJ; Andersen RE; Muller D; Elahi D; Cheskin LJ; Andres R; Roth J; Shuldiner AR
    Diabetes; 1998 Nov; 47(11):1806-8. PubMed ID: 9792554
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenetic Aspects of Sarcopenic Obesity.
    Mazurkiewicz Ł; Czernikiewicz K; Grygiel-Górniak B
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity-Related Kidney Disease: Current Understanding and Future Perspectives.
    Kreiner FF; Schytz PA; Heerspink HJL; von Scholten BJ; Idorn T
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin: friend or foe in obesity and inflammation.
    Luo L; Liu M
    Med Rev (2021); 2022 Aug; 2(4):349-362. PubMed ID: 37724325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipose Tissue Hyperplasia and Hypertrophy in Common and Syndromic Obesity-The Case of BBS Obesity.
    Horwitz A; Birk R
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571382
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.